ArticleJournal of pharmaceutical analysis2026
h3B7A-LDM, a novel anti-mesothelin antibody-drug conjugate with the potential to induce antitumor immunity, shows potent efficacy against solid tumors.
Dan-Dan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.